Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CEN inhibitors(cap-dependent endonuclease inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H17F2N3O4S |
InChIKeyFZUANDXZHWCVPH-MSOLQXFVSA-N |
CAS Registry3049172-60-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza A virus infection | Preclinical | China | 10 Dec 2024 | |
Influenza B virus infection | Preclinical | China | 10 Dec 2024 |